Target Name: TRMT1L
NCBI ID: G81627
Review Report on TRMT1L Target / Biomarker Content of Review Report on TRMT1L Target / Biomarker
TRMT1L
Other Name(s): tRNA methyltransferase 1 homolog-like | tRNA methyltransferase 1 homolog | bG120K12.3 | TRMT1-like protein | TRNA methyltransferase 1 like, transcript variant 1 | TRM1L | TRMT1L variant 1 | C1orf25 | TRM1L_HUMAN | MST070 | tRNA methyltransferase 1 like | TRM1-like protein | TRMT1-like protein (isoform 1) | MSTP070 | TRM1 tRNA methyltransferase 1-like

TRMT1L: A Non-coding RNA Molecule Involved in RNA Methylation and Protein Translation Regulation

TRMT1L, also known as tRNA methyltransferase 1 homolog-like, is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in various organisms, including humans. The TRMT1L gene has been shown to be involved in the process of RNA methylation, which involves the addition of methyl groups to specific locations on RNA molecules.

TRMT1L is a member of the TRMTase family, which includes several conserved RNA-binding proteins that share a common catalytic core. These proteins are involved in the regulation of various cellular processes, including chromatin remodeling, gene expression, and translation.

One of the unique features of TRMT1L is its ability to transfer methyl groups to specific locations on RNA molecules. This process is known as RNA methylation, and it involves the addition of methyl groups to specific positions on the RNA molecule. Methylation of RNA molecules has has been shown to play a role in the regulation of gene expression, and the TRMT1L gene is thought to be involved in this process.

In addition to its role in RNA methylation, TRMT1L is also involved in the regulation of protein translation. This is accomplished through its interaction with the protein chaperone TRMT2, which is a critical regulator of protein translation. TRMT1L has been shown to interact with TRMT2 and to play a role in the regulation of TRMT2 function.

TRMT1L has also been shown to be involved in the regulation of gene expression in various organisms, including bacteria and yeast. For example, studies have shown that TRMT1L is involved in the regulation of gene expression in E. coli, and that it plays a role in the regulation of protein synthesis in these organisms.

In addition to its role in regulating gene expression, TRMT1L has also been shown to be involved in the regulation of RNA stability. This is accomplished through its interaction with the protein TRIM2, which is involved in the removal of dead RNA from the cell. TRMT1L has been shown to interact with TRIM2 and to play a role in the regulation of TRIM2 function.

TRMT1L has also been shown to be involved in the regulation of cellular processes that are important for the survival of the cell. For example, studies have shown that TRMT1L is involved in the regulation of cell survival in various organisms, including bacteria and yeast.

Given the multiple roles that TRMT1L is thought to play in various cellular processes, it is thought-provoking that TRMT1L is not yet widely recognized as a drug target or biomarker. While more research is needed to fully understand the functions of TRMT1L and its potential role in drug discovery, its potential as a drug target or biomarker is an exciting area of 鈥嬧?媟esearch that could have significant implications for the development of new therapeutics.

Protein Name: TRNA Methyltransferase 1 Like

Functions: May play a role in motor coordination and exploratory behavior

The "TRMT1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRMT1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TRMT2A | TRMT2B | TRMT44 | TRMT5 | TRMT6 | TRMT61A | TRMT61B | TRMT9B | TRMU | TRN-GTT4-1 | TRNA | tRNA splicing endonuclease complex | tRNA(Sec) complex | tRNA-splicing endonuclease complex | tRNA-splicing ligase complex | TRNAU1AP | TRNC | TRND | TRNE | TRNF | TRNG | TRNH | TRNI | TRNK | TRNL1 | TRNL2 | TRNM | TRNN | TRNP | TRNP1 | TRNQ | TRNR | TRNS1 | TRNS2 | TRNT | TRNT1 | TRNV | TRNW | TRNY | TRO | TROAP | TROAP-AS1 | Troponin | TRP-AGG2-5 | TRP-AGG6-1 | TRPA1 | TRPC1 | TRPC2 | TRPC3 | TRPC4 | TRPC4AP | TRPC5 | TRPC6 | TRPC7 | TRPC7-AS1 | TRPM1 | TRPM2 | TRPM2-AS | TRPM3 | TRPM4 | TRPM5 | TRPM6 | TRPM7 | TRPM8 | TRPS1 | TRPT1 | TRPV1 | TRPV2 | TRPV3 | TRPV4 | TRPV5 | TRPV6 | TRR-ACG1-2 | TRRAP | TRU-TCA2-1 | TRUB1 | TRUB2 | Trypanosome lytic factor 1 | Trypanosome lytic factor 2 | Trypsin | Tryptase | Tryptophan 5-Monooxygenase | TSACC | TSBP1 | TSBP1-AS1 | TSC1 | TSC2 | TSC22D1 | TSC22D1-AS1 | TSC22D2 | TSC22D3 | TSC22D4 | TSEN15 | TSEN2 | TSEN2P1 | TSEN34 | TSEN54 | TSFM | TSG1 | TSG101